$CELZ LONG

21 เม.ย. 2018

Price target .25-.50

Market cap will explode. URA conference coming up at the end of may.
ED procedure already being adopted at big practices with top doctors.
Many more products in the pipeline with massive upside potential in multi billion dollar markets not to mention M&A in big pharma.
Will continue to add.

27 เม.ย. 2018

บันทึก

Wish I had added even more. Hopefully fully debt free soon.
Massive upside here.

2 พ.ค. 2018

บันทึก

Holding to massive spike, or till end of year

11 พ.ค. 2018

บันทึก

Next up, .05

15 พ.ค. 2018

บันทึก

TP: $15, Long hold.
I believe in stem cell research and the effect this company can have.

13 มิ.ย. 2018

บันทึก

Lots of great doctors will start to practice the ED procedure across the U.S

Very good time to own this stock.

25 มิ.ย. 2018

บันทึก

Keep er coming

23 ก.ค. 2018

บันทึก

Consolidating. Lots of good buying pressure. This thing will jump up again in a matter of days. Expect that for the rest of 2018.
GLTA